FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
-33.86%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$62.7M
AUM Growth
+$62.7M
(-54%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-44.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
2
Closed
3
Top Buys
| 1 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$1.41M |
Top Sells
| 1 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$19.6M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$7.86M |
| 3 |
Quantum-Si Incorporated
QSI
|
$1.65M |
| 4 |
Compass Therapeutics
CMPX
|
$152K |
| 5 |
Pharvaris
PHVS
|
$20.9K |
Sector Composition
| 1 | Healthcare | 62.53% |
| 2 | Consumer Staples | 37.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Hims & Hers Health
HIMS
$9.57B
| $23.5M | 37.47% | 3,733,381 | – | – |
|
2
Disc Medicine
IRON
$2.07B
| $11.4M | 18.25% | 243,513 | – | – |
|
|
THRX
3
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $11.1M | 17.63% | 4,108,796 +523,450 | +15% | +$1.41M |
|
4
Aclaris Therapeutics
ACRS
$209M
| $8.62M | 13.75% | 1,258,243 | – | – |
|
|
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $4.94M | 7.88% | 3,525,957 | – | – |
|
|
6
Compass Therapeutics
CMPX
$483M
| $2.46M | 3.92% | 1,246,977 -77,094 | -6% | -$152K |
|
|
7
Pharvaris
PHVS
$1.39B
| $692K | 1.1% | 33,142 -1,000 | -3% | -$20.9K |
|
|
8
Quantum-Si Incorporated
QSI
$227M
| – | – | -924,404 | Closed | -$1.65M |
|
|
SLGC
9
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – | -3,403,276 | Closed | -$7.86M |
|
|
PRDS
10
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – | -10,811,887 | Closed | -$19.6M |
|